Full name
OST-MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.92.Z - Packaging activities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.E - Healthcare
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 4,3 | 3,8 | 3,3 | -14,1 |
Gross profit (loss) | -0 | -1,8 | -1,2 | 33,8 |
EBITDA | 0,2 | -1,5 | -0,9 | 43,6 |
Net profit (loss) | -0 | -1,8 | -1,2 | 33,8 |
Cash | 0,9 | 0 | 0 | 123,5 |
Liabilities and provisions for liabilities | 4,2 | 5,5 | 6,2 | 12,2 |
Net income from sale | 0,3 | 0,5 | 0,5 | -1,7 |
Short time liabilities | 4,1 | 5,4 | 6,1 | 12,4 |
Equity capital | 0,1 | -1,7 | -2,9 | -71,4 |
Working assets | 1,8 | 1 | 0,9 | -7,1 |
Operating profit (EBIT) | 0 | -1,8 | -1,2 | 34 |
Depreciation | 0,2 | 0,3 | 0,3 | 14,9 |
% | % | % | p.p. | |
Profitability of capital | -10,6 | 107,8 | 41,7 | -66,1 |
Equity capital to total assets | 3,1 | -44,5 | -88,8 | -44,3 |
Gross profit margin | -4,2 | -334,5 | -225,4 | 109,1 |
EBITDA Margin | 62,2 | -278,7 | -159,8 | 118,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 4409 | 3621 | 4140 | 519 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane